Xponance, Inc.

SEC CIK: 0001637541
Latest filing: Aug 10, 2026

SEC filings (opens in a new tab)

XENE holding history

Xenon Pharmaceuticals Inc. in every 13F filed by Xponance, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

XENE overview All 13F holders of XENE Full Q2 2026 holdings

Shares (Q2 2026): 9,660
Value: $583.1K
% of portfolio: <0.1%
Quarters held: 4; Since Q3 2025

Holdings of XENE by Xponance, Inc., by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	9,660	$583.1K	<0.1%	+1,195+14.1%	Added	Holders
Q1 2026	8,465	$492.2K	<0.1%	+2,490+41.7%	Added	Holders
Q4 2025	5,975	$267.8K	<0.1%	+8+0.1%	Added	Holders
Q3 2025	5,967	$239.6K	<0.1%	+5,967	New	Holders